Recent research revealed that overexpression of FTO was accompanied by BCL-2 upregulation [69], which was consistent with the trend of regulation of BCL-2 by ALKBH5 found in epithelial ovarian cancer (EOC) [70]. The gene discussed is ALKBH5; the disease is ovarian carcinoma.